nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Temozolomide—melanoma	0.185	0.576	CbGbCtD
Sibutramine—CYP3A4—Vemurafenib—melanoma	0.101	0.316	CbGbCtD
Sibutramine—CYP3A4—Docetaxel—melanoma	0.0348	0.108	CbGbCtD
Sibutramine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A11—melanoma	0.00235	0.059	CbGpPWpGaD
Sibutramine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A11—melanoma	0.00208	0.0522	CbGpPWpGaD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—CDKN1C—melanoma	0.00181	0.0453	CbGpPWpGaD
Sibutramine—SLC6A2—Amine compound SLC transporters—SLC6A11—melanoma	0.00163	0.0409	CbGpPWpGaD
Sibutramine—SLC6A3—Amine compound SLC transporters—SLC6A11—melanoma	0.00144	0.0363	CbGpPWpGaD
Sibutramine—SLC6A4—Serotonin Transporter Activity—ITGB3—melanoma	0.00136	0.0341	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—SLC39A12—melanoma	0.00116	0.0292	CbGpPWpGaD
Sibutramine—Alopecia—Dactinomycin—melanoma	0.00108	0.00169	CcSEcCtD
Sibutramine—Eye disorder—Carmustine—melanoma	0.00107	0.00167	CcSEcCtD
Sibutramine—Visual impairment—Temozolomide—melanoma	0.00106	0.00167	CcSEcCtD
Sibutramine—Pain in extremity—Docetaxel—melanoma	0.00106	0.00166	CcSEcCtD
Sibutramine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00106	0.00166	CcSEcCtD
Sibutramine—Ill-defined disorder—Bleomycin—melanoma	0.00106	0.00165	CcSEcCtD
Sibutramine—Anaemia—Bleomycin—melanoma	0.00105	0.00165	CcSEcCtD
Sibutramine—Diarrhoea—Vemurafenib—melanoma	0.00105	0.00164	CcSEcCtD
Sibutramine—Migraine—Docetaxel—melanoma	0.00104	0.00164	CcSEcCtD
Sibutramine—Eye disorder—Temozolomide—melanoma	0.00103	0.00162	CcSEcCtD
Sibutramine—Tinnitus—Temozolomide—melanoma	0.00103	0.00161	CcSEcCtD
Sibutramine—Malaise—Bleomycin—melanoma	0.00103	0.00161	CcSEcCtD
Sibutramine—Arrhythmia—Carmustine—melanoma	0.00102	0.0016	CcSEcCtD
Sibutramine—Leukopenia—Bleomycin—melanoma	0.00102	0.0016	CcSEcCtD
Sibutramine—Dizziness—Vemurafenib—melanoma	0.00101	0.00159	CcSEcCtD
Sibutramine—Alopecia—Carmustine—melanoma	0.00101	0.00158	CcSEcCtD
Sibutramine—Angiopathy—Temozolomide—melanoma	0.001	0.00157	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—SLC39A12—melanoma	0.001	0.0251	CbGpPWpGaD
Sibutramine—Ataxia—Docetaxel—melanoma	0.000998	0.00156	CcSEcCtD
Sibutramine—Immune system disorder—Temozolomide—melanoma	0.000997	0.00156	CcSEcCtD
Sibutramine—Malnutrition—Carmustine—melanoma	0.000994	0.00156	CcSEcCtD
Sibutramine—Cough—Bleomycin—melanoma	0.000994	0.00156	CcSEcCtD
Sibutramine—Chills—Temozolomide—melanoma	0.000991	0.00155	CcSEcCtD
Sibutramine—Dehydration—Docetaxel—melanoma	0.000987	0.00155	CcSEcCtD
Sibutramine—Ill-defined disorder—Dactinomycin—melanoma	0.000986	0.00154	CcSEcCtD
Sibutramine—Anaemia—Dactinomycin—melanoma	0.000982	0.00154	CcSEcCtD
Sibutramine—Liver function test abnormal—Docetaxel—melanoma	0.00098	0.00153	CcSEcCtD
Sibutramine—Vomiting—Vemurafenib—melanoma	0.000976	0.00153	CcSEcCtD
Sibutramine—Alopecia—Temozolomide—melanoma	0.000976	0.00153	CcSEcCtD
Sibutramine—Dry skin—Docetaxel—melanoma	0.000973	0.00152	CcSEcCtD
Sibutramine—Myalgia—Bleomycin—melanoma	0.00097	0.00152	CcSEcCtD
Sibutramine—Chest pain—Bleomycin—melanoma	0.00097	0.00152	CcSEcCtD
Sibutramine—Orthostatic hypotension—Docetaxel—melanoma	0.000969	0.00152	CcSEcCtD
Sibutramine—Rash—Vemurafenib—melanoma	0.000968	0.00151	CcSEcCtD
Sibutramine—Dermatitis—Vemurafenib—melanoma	0.000967	0.00151	CcSEcCtD
Sibutramine—Back pain—Carmustine—melanoma	0.000962	0.00151	CcSEcCtD
Sibutramine—Headache—Vemurafenib—melanoma	0.000961	0.00151	CcSEcCtD
Sibutramine—Malnutrition—Temozolomide—melanoma	0.000961	0.0015	CcSEcCtD
Sibutramine—Discomfort—Bleomycin—melanoma	0.000958	0.0015	CcSEcCtD
Sibutramine—Malaise—Dactinomycin—melanoma	0.000958	0.0015	CcSEcCtD
Sibutramine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000956	0.0015	CcSEcCtD
Sibutramine—Leukopenia—Dactinomycin—melanoma	0.000951	0.00149	CcSEcCtD
Sibutramine—Dysgeusia—Temozolomide—melanoma	0.000941	0.00147	CcSEcCtD
Sibutramine—Confusional state—Bleomycin—melanoma	0.000938	0.00147	CcSEcCtD
Sibutramine—Vision blurred—Carmustine—melanoma	0.000937	0.00147	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000936	0.00147	CcSEcCtD
Sibutramine—Tremor—Carmustine—melanoma	0.000932	0.00146	CcSEcCtD
Sibutramine—Oedema—Bleomycin—melanoma	0.00093	0.00146	CcSEcCtD
Sibutramine—Anaphylactic shock—Bleomycin—melanoma	0.00093	0.00146	CcSEcCtD
Sibutramine—Back pain—Temozolomide—melanoma	0.00093	0.00146	CcSEcCtD
Sibutramine—Infection—Bleomycin—melanoma	0.000924	0.00145	CcSEcCtD
Sibutramine—Anaemia—Carmustine—melanoma	0.000919	0.00144	CcSEcCtD
Sibutramine—Dysphagia—Docetaxel—melanoma	0.000917	0.00144	CcSEcCtD
Sibutramine—Agitation—Carmustine—melanoma	0.000914	0.00143	CcSEcCtD
Sibutramine—Nausea—Vemurafenib—melanoma	0.000912	0.00143	CcSEcCtD
Sibutramine—Thrombocytopenia—Bleomycin—melanoma	0.00091	0.00143	CcSEcCtD
Sibutramine—Vision blurred—Temozolomide—melanoma	0.000906	0.00142	CcSEcCtD
Sibutramine—Myalgia—Dactinomycin—melanoma	0.000905	0.00142	CcSEcCtD
Sibutramine—Tremor—Temozolomide—melanoma	0.0009	0.00141	CcSEcCtD
Sibutramine—Discomfort—Dactinomycin—melanoma	0.000894	0.0014	CcSEcCtD
Sibutramine—Angina pectoris—Docetaxel—melanoma	0.000893	0.0014	CcSEcCtD
Sibutramine—Ill-defined disorder—Temozolomide—melanoma	0.000892	0.0014	CcSEcCtD
Sibutramine—Leukopenia—Carmustine—melanoma	0.00089	0.00139	CcSEcCtD
Sibutramine—Anaemia—Temozolomide—melanoma	0.000888	0.00139	CcSEcCtD
Sibutramine—Anorexia—Bleomycin—melanoma	0.000886	0.00139	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—SLC39A12—melanoma	0.000886	0.0223	CbGpPWpGaD
Sibutramine—Agitation—Temozolomide—melanoma	0.000883	0.00138	CcSEcCtD
Sibutramine—Angioedema—Temozolomide—melanoma	0.000878	0.00137	CcSEcCtD
Sibutramine—Hypotension—Bleomycin—melanoma	0.000869	0.00136	CcSEcCtD
Sibutramine—Oedema—Dactinomycin—melanoma	0.000867	0.00136	CcSEcCtD
Sibutramine—Malaise—Temozolomide—melanoma	0.000867	0.00136	CcSEcCtD
Sibutramine—Vertigo—Temozolomide—melanoma	0.000863	0.00135	CcSEcCtD
Sibutramine—Convulsion—Carmustine—melanoma	0.000862	0.00135	CcSEcCtD
Sibutramine—Infection—Dactinomycin—melanoma	0.000862	0.00135	CcSEcCtD
Sibutramine—Leukopenia—Temozolomide—melanoma	0.00086	0.00135	CcSEcCtD
Sibutramine—Hypertension—Carmustine—melanoma	0.000859	0.00134	CcSEcCtD
Sibutramine—Palpitations—Temozolomide—melanoma	0.000849	0.00133	CcSEcCtD
Sibutramine—Thrombocytopenia—Dactinomycin—melanoma	0.000849	0.00133	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000847	0.00133	CcSEcCtD
Sibutramine—Myalgia—Carmustine—melanoma	0.000847	0.00133	CcSEcCtD
Sibutramine—Chest pain—Carmustine—melanoma	0.000847	0.00133	CcSEcCtD
Sibutramine—Anxiety—Carmustine—melanoma	0.000844	0.00132	CcSEcCtD
Sibutramine—Cough—Temozolomide—melanoma	0.000839	0.00131	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—POU3F2—melanoma	0.000836	0.021	CbGpPWpGaD
Sibutramine—Paraesthesia—Bleomycin—melanoma	0.000835	0.00131	CcSEcCtD
Sibutramine—Weight increased—Docetaxel—melanoma	0.000835	0.00131	CcSEcCtD
Sibutramine—Convulsion—Temozolomide—melanoma	0.000833	0.0013	CcSEcCtD
Sibutramine—Hypertension—Temozolomide—melanoma	0.00083	0.0013	CcSEcCtD
Sibutramine—Dyspnoea—Bleomycin—melanoma	0.000829	0.0013	CcSEcCtD
Sibutramine—Anorexia—Dactinomycin—melanoma	0.000827	0.00129	CcSEcCtD
Sibutramine—Pneumonia—Docetaxel—melanoma	0.000823	0.00129	CcSEcCtD
Sibutramine—Confusional state—Carmustine—melanoma	0.000818	0.00128	CcSEcCtD
Sibutramine—Myalgia—Temozolomide—melanoma	0.000818	0.00128	CcSEcCtD
Sibutramine—Arthralgia—Temozolomide—melanoma	0.000818	0.00128	CcSEcCtD
Sibutramine—Anxiety—Temozolomide—melanoma	0.000815	0.00128	CcSEcCtD
Sibutramine—Oedema—Carmustine—melanoma	0.000812	0.00127	CcSEcCtD
Sibutramine—Discomfort—Temozolomide—melanoma	0.000808	0.00127	CcSEcCtD
Sibutramine—Decreased appetite—Bleomycin—melanoma	0.000808	0.00127	CcSEcCtD
Sibutramine—Infection—Carmustine—melanoma	0.000806	0.00126	CcSEcCtD
Sibutramine—Acute coronary syndrome—Docetaxel—melanoma	0.000806	0.00126	CcSEcCtD
Sibutramine—Renal failure—Docetaxel—melanoma	0.000804	0.00126	CcSEcCtD
Sibutramine—Myocardial infarction—Docetaxel—melanoma	0.000802	0.00126	CcSEcCtD
Sibutramine—Neuropathy peripheral—Docetaxel—melanoma	0.000802	0.00126	CcSEcCtD
Sibutramine—Dry mouth—Temozolomide—melanoma	0.0008	0.00125	CcSEcCtD
Sibutramine—Stomatitis—Docetaxel—melanoma	0.000797	0.00125	CcSEcCtD
Sibutramine—Pain—Bleomycin—melanoma	0.000795	0.00124	CcSEcCtD
Sibutramine—Conjunctivitis—Docetaxel—melanoma	0.000795	0.00124	CcSEcCtD
Sibutramine—Thrombocytopenia—Carmustine—melanoma	0.000795	0.00124	CcSEcCtD
Sibutramine—Tachycardia—Carmustine—melanoma	0.000792	0.00124	CcSEcCtD
Sibutramine—Confusional state—Temozolomide—melanoma	0.000791	0.00124	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00079	0.00124	CcSEcCtD
Sibutramine—Oedema—Temozolomide—melanoma	0.000784	0.00123	CcSEcCtD
Sibutramine—Anaphylactic shock—Temozolomide—melanoma	0.000784	0.00123	CcSEcCtD
Sibutramine—Infection—Temozolomide—melanoma	0.000779	0.00122	CcSEcCtD
Sibutramine—Anorexia—Carmustine—melanoma	0.000774	0.00121	CcSEcCtD
Sibutramine—Epistaxis—Docetaxel—melanoma	0.000771	0.00121	CcSEcCtD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—APAF1—melanoma	0.00077	0.0193	CbGpPWpGaD
Sibutramine—Thrombocytopenia—Temozolomide—melanoma	0.000768	0.0012	CcSEcCtD
Sibutramine—Feeling abnormal—Bleomycin—melanoma	0.000766	0.0012	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—RAI1—melanoma	0.000766	0.0192	CbGpPWpGaD
Sibutramine—Skin disorder—Temozolomide—melanoma	0.000762	0.00119	CcSEcCtD
Sibutramine—Hypotension—Carmustine—melanoma	0.000758	0.00119	CcSEcCtD
Sibutramine—Hyperhidrosis—Temozolomide—melanoma	0.000758	0.00119	CcSEcCtD
Sibutramine—Decreased appetite—Dactinomycin—melanoma	0.000754	0.00118	CcSEcCtD
Sibutramine—Anorexia—Temozolomide—melanoma	0.000748	0.00117	CcSEcCtD
Sibutramine—Pain—Dactinomycin—melanoma	0.000742	0.00116	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Carmustine—melanoma	0.000739	0.00116	CcSEcCtD
Sibutramine—Urticaria—Bleomycin—melanoma	0.000739	0.00116	CcSEcCtD
Sibutramine—Haemoglobin—Docetaxel—melanoma	0.000738	0.00116	CcSEcCtD
Sibutramine—Rhinitis—Docetaxel—melanoma	0.000736	0.00115	CcSEcCtD
Sibutramine—Body temperature increased—Bleomycin—melanoma	0.000735	0.00115	CcSEcCtD
Sibutramine—Haemorrhage—Docetaxel—melanoma	0.000734	0.00115	CcSEcCtD
Sibutramine—Insomnia—Carmustine—melanoma	0.000734	0.00115	CcSEcCtD
Sibutramine—Hypoaesthesia—Docetaxel—melanoma	0.00073	0.00114	CcSEcCtD
Sibutramine—Paraesthesia—Carmustine—melanoma	0.000729	0.00114	CcSEcCtD
Sibutramine—Pharyngitis—Docetaxel—melanoma	0.000729	0.00114	CcSEcCtD
Sibutramine—Dyspnoea—Carmustine—melanoma	0.000724	0.00113	CcSEcCtD
Sibutramine—Oedema peripheral—Docetaxel—melanoma	0.000723	0.00113	CcSEcCtD
Sibutramine—Somnolence—Carmustine—melanoma	0.000722	0.00113	CcSEcCtD
Sibutramine—Feeling abnormal—Dactinomycin—melanoma	0.000715	0.00112	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000715	0.00112	CcSEcCtD
Sibutramine—Insomnia—Temozolomide—melanoma	0.000709	0.00111	CcSEcCtD
Sibutramine—Gastrointestinal pain—Dactinomycin—melanoma	0.000709	0.00111	CcSEcCtD
Sibutramine—Visual impairment—Docetaxel—melanoma	0.000708	0.00111	CcSEcCtD
Sibutramine—Decreased appetite—Carmustine—melanoma	0.000706	0.0011	CcSEcCtD
Sibutramine—Paraesthesia—Temozolomide—melanoma	0.000704	0.0011	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Carmustine—melanoma	0.000701	0.0011	CcSEcCtD
Sibutramine—Dyspnoea—Temozolomide—melanoma	0.000699	0.00109	CcSEcCtD
Sibutramine—Somnolence—Temozolomide—melanoma	0.000697	0.00109	CcSEcCtD
Sibutramine—Pain—Carmustine—melanoma	0.000694	0.00109	CcSEcCtD
Sibutramine—Constipation—Carmustine—melanoma	0.000694	0.00109	CcSEcCtD
Sibutramine—Dyspepsia—Temozolomide—melanoma	0.00069	0.00108	CcSEcCtD
Sibutramine—SLC6A3—Alpha-synuclein signaling—PTK2B—melanoma	0.000687	0.0172	CbGpPWpGaD
Sibutramine—Eye disorder—Docetaxel—melanoma	0.000686	0.00107	CcSEcCtD
Sibutramine—Abdominal pain—Dactinomycin—melanoma	0.000686	0.00107	CcSEcCtD
Sibutramine—Body temperature increased—Dactinomycin—melanoma	0.000686	0.00107	CcSEcCtD
Sibutramine—Hypersensitivity—Bleomycin—melanoma	0.000685	0.00107	CcSEcCtD
Sibutramine—Decreased appetite—Temozolomide—melanoma	0.000682	0.00107	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Temozolomide—melanoma	0.000677	0.00106	CcSEcCtD
Sibutramine—Pain—Temozolomide—melanoma	0.000671	0.00105	CcSEcCtD
Sibutramine—Constipation—Temozolomide—melanoma	0.000671	0.00105	CcSEcCtD
Sibutramine—Feeling abnormal—Carmustine—melanoma	0.000669	0.00105	CcSEcCtD
Sibutramine—Asthenia—Bleomycin—melanoma	0.000667	0.00104	CcSEcCtD
Sibutramine—Angiopathy—Docetaxel—melanoma	0.000666	0.00104	CcSEcCtD
Sibutramine—Gastrointestinal pain—Carmustine—melanoma	0.000664	0.00104	CcSEcCtD
Sibutramine—Immune system disorder—Docetaxel—melanoma	0.000663	0.00104	CcSEcCtD
Sibutramine—Chills—Docetaxel—melanoma	0.000659	0.00103	CcSEcCtD
Sibutramine—Pruritus—Bleomycin—melanoma	0.000658	0.00103	CcSEcCtD
Sibutramine—Arrhythmia—Docetaxel—melanoma	0.000656	0.00103	CcSEcCtD
Sibutramine—Alopecia—Docetaxel—melanoma	0.000649	0.00102	CcSEcCtD
Sibutramine—Feeling abnormal—Temozolomide—melanoma	0.000646	0.00101	CcSEcCtD
Sibutramine—Abdominal pain—Carmustine—melanoma	0.000642	0.001	CcSEcCtD
Sibutramine—Body temperature increased—Carmustine—melanoma	0.000642	0.001	CcSEcCtD
Sibutramine—Gastrointestinal pain—Temozolomide—melanoma	0.000641	0.001	CcSEcCtD
Sibutramine—Malnutrition—Docetaxel—melanoma	0.000639	0.001	CcSEcCtD
Sibutramine—Hypersensitivity—Dactinomycin—melanoma	0.000639	0.001	CcSEcCtD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000637	0.016	CbGpPWpGaD
Sibutramine—Dysgeusia—Docetaxel—melanoma	0.000626	0.00098	CcSEcCtD
Sibutramine—Urticaria—Temozolomide—melanoma	0.000623	0.000975	CcSEcCtD
Sibutramine—Asthenia—Dactinomycin—melanoma	0.000622	0.000974	CcSEcCtD
Sibutramine—Abdominal pain—Temozolomide—melanoma	0.00062	0.000971	CcSEcCtD
Sibutramine—Body temperature increased—Temozolomide—melanoma	0.00062	0.000971	CcSEcCtD
Sibutramine—Back pain—Docetaxel—melanoma	0.000618	0.000968	CcSEcCtD
Sibutramine—Muscle spasms—Docetaxel—melanoma	0.000614	0.000962	CcSEcCtD
Sibutramine—Hypersensitivity—Carmustine—melanoma	0.000598	0.000936	CcSEcCtD
Sibutramine—Diarrhoea—Dactinomycin—melanoma	0.000593	0.000929	CcSEcCtD
Sibutramine—Vomiting—Bleomycin—melanoma	0.000591	0.000926	CcSEcCtD
Sibutramine—Anaemia—Docetaxel—melanoma	0.000591	0.000925	CcSEcCtD
Sibutramine—Rash—Bleomycin—melanoma	0.000586	0.000918	CcSEcCtD
Sibutramine—Dermatitis—Bleomycin—melanoma	0.000586	0.000917	CcSEcCtD
Sibutramine—SLC6A3—Alpha-synuclein signaling—SYK—melanoma	0.000584	0.0147	CbGpPWpGaD
Sibutramine—Asthenia—Carmustine—melanoma	0.000582	0.000912	CcSEcCtD
Sibutramine—Hypersensitivity—Temozolomide—melanoma	0.000578	0.000905	CcSEcCtD
Sibutramine—SLC6A4—Monoamine Transport—ITGB3—melanoma	0.000577	0.0145	CbGpPWpGaD
Sibutramine—Syncope—Docetaxel—melanoma	0.000573	0.000897	CcSEcCtD
Sibutramine—Leukopenia—Docetaxel—melanoma	0.000572	0.000896	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—EPHA2—melanoma	0.000568	0.0143	CbGpPWpGaD
Sibutramine—Palpitations—Docetaxel—melanoma	0.000565	0.000884	CcSEcCtD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000564	0.0142	CbGpPWpGaD
Sibutramine—Asthenia—Temozolomide—melanoma	0.000563	0.000881	CcSEcCtD
Sibutramine—Loss of consciousness—Docetaxel—melanoma	0.000562	0.000879	CcSEcCtD
Sibutramine—Cough—Docetaxel—melanoma	0.000558	0.000873	CcSEcCtD
Sibutramine—Diarrhoea—Carmustine—melanoma	0.000555	0.000869	CcSEcCtD
Sibutramine—Pruritus—Temozolomide—melanoma	0.000555	0.000869	CcSEcCtD
Sibutramine—Convulsion—Docetaxel—melanoma	0.000554	0.000867	CcSEcCtD
Sibutramine—Nausea—Bleomycin—melanoma	0.000552	0.000865	CcSEcCtD
Sibutramine—Hypertension—Docetaxel—melanoma	0.000552	0.000864	CcSEcCtD
Sibutramine—Vomiting—Dactinomycin—melanoma	0.000551	0.000863	CcSEcCtD
Sibutramine—Rash—Dactinomycin—melanoma	0.000547	0.000856	CcSEcCtD
Sibutramine—Myalgia—Docetaxel—melanoma	0.000544	0.000852	CcSEcCtD
Sibutramine—Chest pain—Docetaxel—melanoma	0.000544	0.000852	CcSEcCtD
Sibutramine—Arthralgia—Docetaxel—melanoma	0.000544	0.000852	CcSEcCtD
Sibutramine—Dizziness—Carmustine—melanoma	0.000537	0.00084	CcSEcCtD
Sibutramine—Diarrhoea—Temozolomide—melanoma	0.000537	0.00084	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—SLC6A11—melanoma	0.000534	0.0134	CbGpPWpGaD
Sibutramine—Dry mouth—Docetaxel—melanoma	0.000532	0.000833	CcSEcCtD
Sibutramine—Confusional state—Docetaxel—melanoma	0.000526	0.000823	CcSEcCtD
Sibutramine—Oedema—Docetaxel—melanoma	0.000522	0.000817	CcSEcCtD
Sibutramine—Anaphylactic shock—Docetaxel—melanoma	0.000522	0.000817	CcSEcCtD
Sibutramine—Dizziness—Temozolomide—melanoma	0.000519	0.000812	CcSEcCtD
Sibutramine—Infection—Docetaxel—melanoma	0.000518	0.000811	CcSEcCtD
Sibutramine—Vomiting—Carmustine—melanoma	0.000516	0.000808	CcSEcCtD
Sibutramine—Nausea—Dactinomycin—melanoma	0.000515	0.000806	CcSEcCtD
Sibutramine—Shock—Docetaxel—melanoma	0.000513	0.000803	CcSEcCtD
Sibutramine—Rash—Carmustine—melanoma	0.000512	0.000801	CcSEcCtD
Sibutramine—Dermatitis—Carmustine—melanoma	0.000511	0.0008	CcSEcCtD
Sibutramine—Thrombocytopenia—Docetaxel—melanoma	0.000511	0.0008	CcSEcCtD
Sibutramine—Tachycardia—Docetaxel—melanoma	0.000509	0.000797	CcSEcCtD
Sibutramine—Headache—Carmustine—melanoma	0.000508	0.000796	CcSEcCtD
Sibutramine—Skin disorder—Docetaxel—melanoma	0.000507	0.000793	CcSEcCtD
Sibutramine—Vomiting—Temozolomide—melanoma	0.000499	0.000781	CcSEcCtD
Sibutramine—Anorexia—Docetaxel—melanoma	0.000497	0.000778	CcSEcCtD
Sibutramine—SLC6A2—Monoamine Transport—ITGB3—melanoma	0.000496	0.0125	CbGpPWpGaD
Sibutramine—CYP3A4—Liver X Receptor Pathway—FASN—melanoma	0.000495	0.0124	CbGpPWpGaD
Sibutramine—Rash—Temozolomide—melanoma	0.000495	0.000774	CcSEcCtD
Sibutramine—Dermatitis—Temozolomide—melanoma	0.000494	0.000774	CcSEcCtD
Sibutramine—Headache—Temozolomide—melanoma	0.000491	0.000769	CcSEcCtD
Sibutramine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—melanoma	0.00049	0.0123	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—EPHA2—melanoma	0.000489	0.0123	CbGpPWpGaD
Sibutramine—Hypotension—Docetaxel—melanoma	0.000487	0.000763	CcSEcCtD
Sibutramine—Nausea—Carmustine—melanoma	0.000482	0.000755	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—MAP2—melanoma	0.00048	0.0121	CbGpPWpGaD
Sibutramine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000475	0.000744	CcSEcCtD
Sibutramine—Insomnia—Docetaxel—melanoma	0.000472	0.000739	CcSEcCtD
Sibutramine—Paraesthesia—Docetaxel—melanoma	0.000468	0.000733	CcSEcCtD
Sibutramine—Nausea—Temozolomide—melanoma	0.000466	0.000729	CcSEcCtD
Sibutramine—Dyspnoea—Docetaxel—melanoma	0.000465	0.000728	CcSEcCtD
Sibutramine—Somnolence—Docetaxel—melanoma	0.000464	0.000726	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—SLC6A11—melanoma	0.000459	0.0115	CbGpPWpGaD
Sibutramine—Dyspepsia—Docetaxel—melanoma	0.000459	0.000719	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—ARNT—melanoma	0.000456	0.0114	CbGpPWpGaD
Sibutramine—Decreased appetite—Docetaxel—melanoma	0.000453	0.00071	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Docetaxel—melanoma	0.00045	0.000705	CcSEcCtD
Sibutramine—Pain—Docetaxel—melanoma	0.000446	0.000698	CcSEcCtD
Sibutramine—Constipation—Docetaxel—melanoma	0.000446	0.000698	CcSEcCtD
Sibutramine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—melanoma	0.000444	0.0111	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PAX4—melanoma	0.00044	0.0111	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—ITGB3—melanoma	0.00044	0.011	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—EPHA2—melanoma	0.000433	0.0109	CbGpPWpGaD
Sibutramine—Feeling abnormal—Docetaxel—melanoma	0.00043	0.000673	CcSEcCtD
Sibutramine—Gastrointestinal pain—Docetaxel—melanoma	0.000427	0.000668	CcSEcCtD
Sibutramine—Body temperature increased—Docetaxel—melanoma	0.000412	0.000646	CcSEcCtD
Sibutramine—Abdominal pain—Docetaxel—melanoma	0.000412	0.000646	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TP73—melanoma	0.000408	0.0103	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—SLC6A11—melanoma	0.000407	0.0102	CbGpPWpGaD
Sibutramine—Hypersensitivity—Docetaxel—melanoma	0.000384	0.000602	CcSEcCtD
Sibutramine—Asthenia—Docetaxel—melanoma	0.000374	0.000586	CcSEcCtD
Sibutramine—Pruritus—Docetaxel—melanoma	0.000369	0.000578	CcSEcCtD
Sibutramine—Diarrhoea—Docetaxel—melanoma	0.000357	0.000559	CcSEcCtD
Sibutramine—Dizziness—Docetaxel—melanoma	0.000345	0.00054	CcSEcCtD
Sibutramine—Vomiting—Docetaxel—melanoma	0.000332	0.000519	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000331	0.00832	CbGpPWpGaD
Sibutramine—Rash—Docetaxel—melanoma	0.000329	0.000515	CcSEcCtD
Sibutramine—Dermatitis—Docetaxel—melanoma	0.000329	0.000514	CcSEcCtD
Sibutramine—Headache—Docetaxel—melanoma	0.000327	0.000512	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCB5—melanoma	0.00032	0.00805	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000319	0.00801	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—SLC6A11—melanoma	0.000316	0.00795	CbGpPWpGaD
Sibutramine—Nausea—Docetaxel—melanoma	0.00031	0.000485	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000293	0.00737	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000289	0.00727	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCB5—melanoma	0.000284	0.00713	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000282	0.0071	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—CYP1B1—melanoma	0.000282	0.00707	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000256	0.00644	CbGpPWpGaD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP1B1—melanoma	0.000249	0.00625	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—SLC5A5—melanoma	0.000244	0.00614	CbGpPWpGaD
Sibutramine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	0.000243	0.0061	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—SLC6A11—melanoma	0.000242	0.00609	CbGpPWpGaD
Sibutramine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000242	0.00609	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—TNF—melanoma	0.000232	0.00582	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ARL2—melanoma	0.000222	0.00558	CbGpPWpGaD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—STAT3—melanoma	0.000215	0.0054	CbGpPWpGaD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—CASP3—melanoma	0.000212	0.00532	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—SLC5A5—melanoma	0.00021	0.00528	CbGpPWpGaD
Sibutramine—CYP3A4—Irinotecan Pathway—APC—melanoma	0.000204	0.00513	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—TNF—melanoma	0.000199	0.00501	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ARL2—melanoma	0.000197	0.00494	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—GNA11—melanoma	0.000196	0.00494	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIN2A—melanoma	0.000193	0.00485	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—SLC5A5—melanoma	0.000186	0.00467	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—HDAC2—melanoma	0.000185	0.00464	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—GNAQ—melanoma	0.000183	0.00459	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—HGF—melanoma	0.000181	0.00454	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—TNF—melanoma	0.000177	0.00444	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL10—melanoma	0.000171	0.00431	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NGFR—melanoma	0.000169	0.00424	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000168	0.00423	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—UGT2B10—melanoma	0.000165	0.00415	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000162	0.00407	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—HGF—melanoma	0.000155	0.00391	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000149	0.00375	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIN2A—melanoma	0.000148	0.00372	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000147	0.0037	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000146	0.00368	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000145	0.00363	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000144	0.00361	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000139	0.0035	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000139	0.0035	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HGF—melanoma	0.000138	0.00346	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	0.000133	0.00334	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000132	0.00333	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00013	0.00327	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000128	0.00321	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000126	0.00317	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—FAS—melanoma	0.000126	0.00315	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000117	0.00295	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—CDK4—melanoma	0.00011	0.00277	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000107	0.0027	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NOS2—melanoma	0.000107	0.0027	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000106	0.00266	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	0.000105	0.00263	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000104	0.0026	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—PRKCA—melanoma	0.000102	0.00255	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PPARG—melanoma	0.0001	0.00252	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	9.7e-05	0.00244	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—melanoma	9.38e-05	0.00236	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CASP3—melanoma	8.97e-05	0.00225	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	8.71e-05	0.00219	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—melanoma	8.65e-05	0.00217	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—melanoma	8.39e-05	0.00211	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—PRKCA—melanoma	7.78e-05	0.00195	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—melanoma	7.62e-05	0.00191	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—BRAF—melanoma	7.47e-05	0.00188	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PTEN—melanoma	6.88e-05	0.00173	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—melanoma	6.73e-05	0.00169	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TNF—melanoma	6.53e-05	0.00164	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—ALB—melanoma	6.31e-05	0.00159	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—MDM2—melanoma	6.26e-05	0.00157	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—MDM2—melanoma	6.21e-05	0.00156	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—melanoma	5.96e-05	0.0015	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—BRAF—melanoma	5.73e-05	0.00144	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—ALB—melanoma	5.59e-05	0.00141	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP17A1—melanoma	5.5e-05	0.00138	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	5.42e-05	0.00136	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6—melanoma	5.27e-05	0.00132	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCB1—melanoma	5.13e-05	0.00129	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—MDM2—melanoma	4.8e-05	0.00121	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TP53—melanoma	4.7e-05	0.00118	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP1B1—melanoma	4.63e-05	0.00116	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	4.56e-05	0.00115	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCB1—melanoma	4.54e-05	0.00114	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—IL6—melanoma	4.3e-05	0.00108	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—MAPK1—melanoma	4.28e-05	0.00108	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—HRAS—melanoma	3.44e-05	0.000863	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—MAPK1—melanoma	3.28e-05	0.000824	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ALB—melanoma	3.21e-05	0.000806	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACER3—melanoma	3.09e-05	0.000775	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ALB—melanoma	2.84e-05	0.000714	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—UGT2B10—melanoma	2.82e-05	0.000709	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—HRAS—melanoma	2.63e-05	0.000661	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HS3ST5—melanoma	2.62e-05	0.000659	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLCB4—melanoma	1.99e-05	0.000499	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC6A11—melanoma	1.87e-05	0.00047	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.87e-05	0.00047	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MTAP—melanoma	1.82e-05	0.000457	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LUM—melanoma	1.62e-05	0.000407	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PHGDH—melanoma	1.62e-05	0.000407	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HPSE—melanoma	1.59e-05	0.000399	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CUBN—melanoma	1.56e-05	0.000392	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SDHD—melanoma	1.51e-05	0.000379	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CSPG4—melanoma	1.51e-05	0.000379	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—BSG—melanoma	1.51e-05	0.000379	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPAM—melanoma	1.46e-05	0.000367	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLA2G6—melanoma	1.24e-05	0.000312	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—VCAN—melanoma	1.11e-05	0.00028	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP17A1—melanoma	9.4e-06	0.000236	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GNA11—melanoma	8.88e-06	0.000223	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—FASN—melanoma	8.69e-06	0.000218	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC5A5—melanoma	8.55e-06	0.000215	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GNAQ—melanoma	8.26e-06	0.000207	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CD44—melanoma	8.26e-06	0.000207	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP1B1—melanoma	7.92e-06	0.000199	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCB1—melanoma	6.52e-06	0.000164	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PRKCA—melanoma	6e-06	0.000151	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ERCC2—melanoma	5.95e-06	0.000149	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CG—melanoma	4.7e-06	0.000118	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARG—melanoma	4.53e-06	0.000114	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CD—melanoma	4.13e-06	0.000104	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALB—melanoma	4.08e-06	0.000102	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CB—melanoma	3.6e-06	9.04e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS2—melanoma	3.57e-06	8.96e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTEN—melanoma	3.11e-06	7.82e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CA—melanoma	2.19e-06	5.51e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKT1—melanoma	1.79e-06	4.5e-05	CbGpPWpGaD
